Shapiro AD - Search Results

1

Treatment of bleeding episodes with recombinant factor VIII Fc fusion protein in A-LONG study subjects with severe haemophilia A.

Shapiro AD, Mahlangu JN, Perry D, Pasi J, Quon DV, Chowdary P, Tsao E, Li S, Innes A, Pierce GF, Allen GA. Shapiro AD, et al. Haemophilia. 2017 May;23(3):392-399. doi: 10.1111/hae.13144. Epub 2017 Feb 20. Haemophilia. 2017. PMID: 28220631 Clinical Trial.

2

Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.

Key NS, Aledort LM, Beardsley D, Cooper HA, Davignon G, Ewenstein BM, Gilchrist GS, Gill JC, Glader B, Hoots WK, Kisker CT, Lusher JM, Rosenfield CG, Shapiro AD, Smith H, Taft E. Key NS, et al. Among authors: shapiro ad. Thromb Haemost. 1998 Dec;80(6):912-8. Thromb Haemost. 1998. PMID: 9869160 Clinical Trial.

3

Recombinant factor VIIa in the treatment of bleeding in hemophilic children with inhibitors.

Shapiro AD. Shapiro AD. Semin Thromb Hemost. 2000;26(4):413-9. doi: 10.1055/s-2000-8461. Semin Thromb Hemost. 2000. PMID: 11092217 Review.

4

Pharmacokinetics of recombinant factor IX in relation to age of the patient: implications for dosing in prophylaxis.

Björkman S, Shapiro AD, Berntorp E. Björkman S, et al. Among authors: shapiro ad. Haemophilia. 2001 Mar;7(2):133-9. doi: 10.1046/j.1365-2516.2001.00465.x. Haemophilia. 2001. PMID: 11260271

5

Haemophilia 2002: emerging risks of treatment.

Evatt BL, Farrugia A, Shapiro AD, Wilde JT. Evatt BL, et al. Among authors: shapiro ad. Haemophilia. 2002 May;8(3):221-9. doi: 10.1046/j.1365-2516.2002.00612.x. Haemophilia. 2002. PMID: 12010415 Review.

6

A global view on prophylaxis: possibilities and consequences.

Shapiro AD. Shapiro AD. Haemophilia. 2003 May;9 Suppl 1:10-7; discussion 18. doi: 10.1046/j.1365-2516.9.s1.2.x. Haemophilia. 2003. PMID: 12709032 Review.

7

Surveillance of infectious complications associated with central venous access devices in children with haemophilia.

Tarantino MD, Lail A, Donfield SM, Lynn H, Peddle L, Hunsberger S, Shapiro AD. Tarantino MD, et al. Among authors: shapiro ad. Haemophilia. 2003 Sep;9(5):588-92. doi: 10.1046/j.1365-2516.2003.00793.x. Haemophilia. 2003. PMID: 14511299

8

Why is primary prophylaxis underutilized in the United States?

Shapiro AD. Shapiro AD. Haemophilia. 2003 Nov;9(6):670-2. doi: 10.1046/j.1351-8216.2003.00833.x. Haemophilia. 2003. PMID: 14750931

9

Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin-free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A.

Tarantino MD, Collins PW, Hay CR, Shapiro AD, Gruppo RA, Berntorp E, Bray GL, Tonetta SA, Schroth PC, Retzios AD, Rogy SS, Sensel MG, Ewenstein BM; RAHF-PFM Clinical Study Group. Tarantino MD, et al. Among authors: shapiro ad. Haemophilia. 2004 Sep;10(5):428-37. doi: 10.1111/j.1365-2516.2004.00932.x. Haemophilia. 2004. PMID: 15357767 Clinical Trial.

10

Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry.

Parameswaran R, Shapiro AD, Gill JC, Kessler CM; HTRS Registry Investigators. Parameswaran R, et al. Among authors: shapiro ad. Haemophilia. 2005 Mar;11(2):100-6. doi: 10.1111/j.1365-2516.2005.01075.x. Haemophilia. 2005. PMID: 15810910

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182 results

Search Page

Filters